Acarbose for Patients with Hypertension and Impaired Glucose Tolerance [1] (multiple letters)

JAMA

Volumn 290, Issue 23, 2003, Pages 3066-3069

  Rosenthal, Julian H ^a   Kaiser, Thomas ^b   Sawicki, Peter T ^b   Bridges, Claude M ^c   González Clemente, José Miguel ^d   De Victoria, Emilio Ortega Martínez ^d   Giménez Palop, Olga ^d   Mauricio, Dídac ^d   Chiasson, Jean Louis ^e   Josse, Robert G ^e   Gomis, Ramon ^e   Hanefeld, Markolf ^e   Karasik, Avraham ^e   Laakso, Markku ^e  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b St Franziskus Hospital Koln   (Germany)

^c MAYO CLINIC   (United States)

^d HOSPITAL DE SABADELL   (Spain)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTYRIC ACID; DIURETIC AGENT; FECES LIPID; GLIBENCLAMIDE; GLUCAGON LIKE PEPTIDE; PLACEBO; ANTIDIABETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BODY MASS; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LETTER; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; RISK;

ACARBOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; GLYBURIDE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; RISK;

EID: 85003347069     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.23.3066-a     Document Type: Letter

References (0)